• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种族、族裔、血统与药物遗传学。

Race, ethnicity, ancestry, and pharmacogenetics.

作者信息

Urban Thomas J

机构信息

Duke University, Durham, NC, USA.

出版信息

Mt Sinai J Med. 2010 Mar-Apr;77(2):133-9. doi: 10.1002/msj.20168.

DOI:10.1002/msj.20168
PMID:20309922
Abstract

Pharmacogenetics is the study of how genetic variation influences the response to drugs. The concepts of race, ethnicity, and ancestry have long had a strong influence on pharmacogenetic discovery and on our understanding of population-level differences in drug response. The primary goal of pharmacogenetics, however, is to identify the individual genetic determinants of drug activity so that therapy can be tailored to the individual patient. This article describes the relationship between the concepts of race, ethnicity, and ancestry and how these concepts have been applied to pharmacogenetics, and it provides examples of the benefits and pitfalls associated with the use of racial or ethnic labels in genetic studies. The future of pharmacogenetics, including the study of rare genetic variation and what this means for racial or ethnic disparities in pharmacogenetic discovery, is also discussed.

摘要

药物遗传学是研究基因变异如何影响药物反应的学科。种族、民族和祖先的概念长期以来对药物遗传学的发现以及我们对药物反应中人群水平差异的理解产生了重大影响。然而,药物遗传学的主要目标是确定药物活性的个体基因决定因素,以便能够为个体患者量身定制治疗方案。本文描述了种族、民族和祖先概念之间的关系,以及这些概念如何应用于药物遗传学,并提供了在基因研究中使用种族或民族标签相关的益处和陷阱的示例。还讨论了药物遗传学的未来,包括罕见基因变异的研究以及这对药物遗传学发现中的种族或民族差异意味着什么。

相似文献

1
Race, ethnicity, ancestry, and pharmacogenetics.种族、族裔、血统与药物遗传学。
Mt Sinai J Med. 2010 Mar-Apr;77(2):133-9. doi: 10.1002/msj.20168.
2
Enhancing race-based prescribing precision with pharmacogenomics.利用药物基因组学提高基于种族的处方精准度。
Clin Pharmacol Ther. 2007 Mar;81(3):323-5. doi: 10.1038/sj.clpt.6100080.
3
The ethical implications of stratifying by race in pharmacogenomics.药物基因组学中按种族分层的伦理问题。
Clin Pharmacol Ther. 2007 Jan;81(1):122-5. doi: 10.1038/sj.clpt.6100020.
4
Race and ethnicity in the era of emerging pharmacogenomics.新兴药物基因组学时代的种族与族裔
J Clin Pharmacol. 2006 Apr;46(4):405-7. doi: 10.1177/0091270005286028.
5
How does race/ethnicity influence pharmacological response to asthma therapies?种族/民族如何影响哮喘治疗药物的药理反应?
Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):435-446. doi: 10.1080/17425255.2018.1449833. Epub 2018 Mar 12.
6
Pharmacogenomics and the challenge of health disparities.药物基因组学与健康差异挑战
Public Health Genomics. 2009;12(3):170-9. doi: 10.1159/000189630. Epub 2009 Feb 10.
7
Genes, race, ethnicity, and environment.基因、种族、族裔与环境。
Mt Sinai J Med. 2010 Mar-Apr;77(2):131-2. doi: 10.1002/msj.20177.
8
Pharmacogenetics: has it reached the clinic?药物遗传学:它进入临床应用了吗?
J Gend Specif Med. 2002 Mar-Apr;5(2):13-8.
9
Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools.骨质疏松症相关骨折的药物遗传学:朝着多态性诊断工具的协调和验证方向发展。
Pharmacogenomics. 2010 Sep;11(9):1287-303. doi: 10.2217/pgs.10.116.
10
Pharmacogenetics in biological perspective.生物学视角下的药物遗传学。
Pharmacol Rev. 1997 Dec;49(4):369-79.

引用本文的文献

1
ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations.ESR1基因变异与次大陆基因组祖先:来自千人基因组计划和美洲原住民群体的见解
Clin Pharmacol Ther. 2025 Jul;118(1):232-241. doi: 10.1002/cpt.3681. Epub 2025 Apr 17.
2
Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022.癌症临床试验中的种族起源:被高估还是被低估?对2020年至2022年间导致美国食品药品监督管理局(FDA)和欧洲药品管理局(EMA)批准的癌症临床试验的综合分析。
ESMO Open. 2025 Jan;10(1):104093. doi: 10.1016/j.esmoop.2024.104093. Epub 2025 Jan 3.
3
Reporting results in U.S. clinical trials for obstructive sleep apnea and insomnia: How transparent are they?
报告美国阻塞性睡眠呼吸暂停和失眠临床试验结果:它们有多透明?
Sleep Health. 2020 Aug;6(4):529-533. doi: 10.1016/j.sleh.2019.11.009. Epub 2020 Mar 14.
4
Pharmacogenomics of poor drug metabolism in Greyhounds: Cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization.灰狗中药物代谢不良的药物基因组学:细胞色素 P450(CYP)2B11 遗传变异、品种分布和功能特征。
Sci Rep. 2020 Jan 9;10(1):69. doi: 10.1038/s41598-019-56660-z.
5
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications.药物遗传学研究中种族和民族分类的不一致性及其潜在的临床意义。
Pharmgenomics Pers Med. 2019 Jul 2;12:107-123. doi: 10.2147/PGPM.S207449. eCollection 2019.
6
Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.种族/民族对诊断为生殖细胞瘤的儿童和青少年的生存差异。
Int J Cancer. 2020 May 1;146(9):2433-2441. doi: 10.1002/ijc.32569. Epub 2019 Jul 31.
7
Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.标准化的生物地理分组系统,用于注释遗传药理学研究中的群体。
Clin Pharmacol Ther. 2019 May;105(5):1256-1262. doi: 10.1002/cpt.1322. Epub 2019 Jan 21.
8
The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.药物表观基因组学信息流程定义了新的和已知的华法林药物基因组学变异的一条途径。
Pharmacogenomics. 2018 Apr;19(5):413-434. doi: 10.2217/pgs-2017-0186. Epub 2018 Feb 5.
9
Minimum information required for a DMET experiment reporting.药物代谢酶和转运体基因多态性检测(DMET)实验报告所需的最低信息。
Pharmacogenomics. 2016 Sep;17(14):1533-45. doi: 10.2217/pgs-2016-0015. Epub 2016 Aug 22.
10
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.药物遗传学等位基因命名法:检测结果报告的国际工作组建议
Clin Pharmacol Ther. 2016 Feb;99(2):172-85. doi: 10.1002/cpt.280. Epub 2015 Nov 20.